OMA Vendor Directory
Find great resources for your obesity medicine practice.
Search the Obesity Medicine Association’s Vendor Directory to find the right resources for your practice. Vendors listed offer a variety of products, services, technologies, and solutions for your obesity medicine practice.
Disclaimer: The Obesity Medicine Association (OMA) presents a forum for its members to be exposed to various products and services. It is the responsibility of each member to do due diligence, including reviewing literature, lectures, and background information. The individual is also responsible for becoming familiar with laws on prescribing limitations within his or her own state before practicing various therapies. OMA does not endorse, approve, or sponsor any products or services.
Browse by Category:
PreventScripts
PreventScripts is the preventive health platform that reconnects providers to their calling and motivates patients to go from uninspired to active and healthy. Through our science-backed digital tool that assesses and monitors at-risk patients, we encourage behavior changes while offering reimbursable tools providers want and patients need.
Eli Lilly and Company
An Obesity Medicine Association Corporate Council Member
Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world.
InBody
An Obesity Medicine Association Corporate Council Member
Powered by groundbreaking BIA technology, InBody offers body composition analyzers, body water analyzers, blood pressure monitors, and other devices that are integrated with a cloud solution for managing patient data as well as EMR/EHR software.
KORR Medical Technologies
Monitor metabolic rates with ease and precision using the ReeVue by KORR. Screen for abnormally low metabolic rates and prevent weight-loss plateaus before they happen.
Novo Nordisk
An Obesity Medicine Association Corporate Council Member
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.
Rhythm Pharmaceuticals, Inc.
An Obesity Medicine Association Corporate Council Member
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.
VIVUS, Inc.
An Obesity Medicine Association Corporate Council Member
VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs.
Currax
An Obesity Medicine Association Corporate Council Member
Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two causes of preventable death in the United States: smoking and obesity. Currax is proud to celebrate being recognized as a 2022 Best Places to Work by Nashville Business Journal thanks to our talented and hard-working employees.
Seca
An Obesity Medicine Association Corporate Council Member
It is often the little things in life that are of great importance. In everyday medical practice sometimes a single gram can make all the difference in terms of our health. With seca, you have a partner at your side supplying you with the basis for your work at the highest level: with ultra-precise, timeless modern scales and measuring systems. Since 1840 we have been paving the way for measuring and weighing, making us the worldwide market leader in our field. This trust in us encourages us to continue with the same level of commitment every day.
Boehringer Ingelheim
An Obesity Medicine Association Corporate Council Member
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacturing and marketing of innovative health care products. Building on our legacy of innovative treatments for a range of cardiovascular, renal and metabolic conditions, our R&D strategy takes a holistic view of the needs of people with metabolic diseases such as diabetes, who often have multiple, related conditions. We are pursuing the next wave of potential innovative medicines for obesity, kidney and liver diseases – including non-alcoholic steatohepatitis (NASH).
Showing 1-10 of 12 results
Vendor Directory Listing
Submit your application for your organization to be listed in the Vendor Directory. Organizations are listed in the online directory and included in the monthly OMA newsletter.